Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lyudmyla Berim, MD
Rutgers Cancer Institute of New Jersey
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rwjbarnabas Health - Robert Wood Johnson University Hospital, Hamilton
Hamilton, New Jersey, United States
- Rwjbarnabas Health - Jersey City Medical Center, Jersey City
Jersey City, New Jersey, United States
- Rwjbarnabas Health - Saint Barnabas Medical Center, Livingston
Livingston, New Jersey, United States
- Monmouth Medical Center
Long Branch, New Jersey, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Rwjbarnabas Health - Newark Beth Israel Medical Center
Newark, New Jersey, United States
- Rwjbarnabas Health - Robert Wood Johnson University Hospital, Somerset
Somerset, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jan 2021
- Primary completion
- 30 Sept 2024
- Completion
- 1 Jun 2025
- Last update posted
- 16 May 2024
- Registered enrollment
- 30
- Registry id
- NCT04672005
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.